Canoe Financial LP Sells 2,100 Shares of Mettler-Toledo International, Inc. $MTD

Canoe Financial LP lessened its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 3.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 56,124 shares of the medical instruments supplier’s stock after selling 2,100 shares during the quarter. Canoe Financial LP owned approximately 0.27% of Mettler-Toledo International worth $68,898,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in MTD. WPG Advisers LLC purchased a new stake in shares of Mettler-Toledo International during the 1st quarter worth $41,000. NewSquare Capital LLC lifted its position in shares of Mettler-Toledo International by 94.4% during the second quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock valued at $41,000 after buying an additional 17 shares during the last quarter. MV Capital Management Inc. lifted its position in shares of Mettler-Toledo International by 50.0% during the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 12 shares during the last quarter. State of Wyoming bought a new stake in shares of Mettler-Toledo International in the 2nd quarter valued at about $58,000. Finally, Sound Income Strategies LLC grew its position in shares of Mettler-Toledo International by 477.8% in the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after buying an additional 43 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on MTD shares. Citigroup increased their target price on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective for the company in a report on Monday, December 15th. Morgan Stanley started coverage on Mettler-Toledo International in a research note on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 target price on the stock. Stifel Nicolaus upped their target price on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Finally, JPMorgan Chase & Co. raised their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $1,441.67.

Insider Activity at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 474 shares of the business’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $1,433.57, for a total value of $679,512.18. Following the completion of the transaction, the director owned 311 shares of the company’s stock, valued at $445,840.27. The trade was a 60.38% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Gerry Keller sold 236 shares of the firm’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the sale, the insider directly owned 159 shares in the company, valued at approximately $225,554.22. This trade represents a 59.75% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 19,565 shares of company stock valued at $28,683,737 over the last ninety days. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Stock Up 0.2%

Mettler-Toledo International stock opened at $1,417.16 on Friday. The stock has a 50-day moving average price of $1,418.62 and a 200 day moving average price of $1,307.12. The company has a market capitalization of $28.95 billion, a price-to-earnings ratio of 35.34, a price-to-earnings-growth ratio of 4.58 and a beta of 1.40. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The company had revenue of $1.03 billion during the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. Mettler-Toledo International’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the firm posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.